ESSEX BIO-TECH(01061),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01061 ESSEX BIO-TECH

Trading 06-05 14:55:31

2.680

-0.030

-1.11%

High2.850	Low2.680	Vol674.00K
Open2.800	D1 Closing2.710	Amplitude6.27%
Mkt Cap1.52B	Tradable Cap1.52B	Total Shares567.00M
T/O1.85M	T/O Rate0.12%	Tradable Shares567.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01061","market":"HK","secType":"STK","nameCN":"ESSEX BIO-TECH","latestPrice":2.68,"timestamp":1780641731529,"preClose":2.71,"halted":0,"volume":674000,"delay":0,"changeRate":-0.01107011070110694,"floatShares":567000000,"shares":567000000,"eps":0.561,"marketStatus":"Trading","change":-0.03,"latestTime":"06-05 14:55:31","open":2.8,"high":2.85,"low":2.68,"amount":1846100,"amplitude":0.062731,"askPrice":2.72,"askSize":217000,"bidPrice":2.68,"bidSize":14000,"shortable":0,"etf":0,"ttmEps":0.561,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1780647000000},"marketStatusCode":2,"adr":0,"listingDate":993571200000,"exchange":"SEHK","adjPreClose":2.71,"dividendRate":0.052239,"openAndCloseTimeList":[[1780623000000,1780632000000],[1780635600000,1780646400000]],"volumeRatio":1.103091,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01061","defaultTab":"news","newsList":[{"id":"1122040423","title":"ESSEX BIO-TECH Reports Stable Share Capital and Confirms Public Float Compliance for May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1122040423","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122040423?lang=en_us&edition=fundamental","pubTime":"2026-06-02 12:23","pubTimestamp":1780374193,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology Limited (ESSEX BIO-TECH) filed its Monthly Return for the period ended 31 May 2026, showing no movement in either authorised or issued share capital. Authorised Share Capital   •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637374427","title":"Essex Bio-Technology Limited (HKG:1061) Looks Interesting, And It's About To Pay A Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2637374427","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637374427?lang=en_us&edition=fundamental","pubTime":"2026-05-24 08:44","pubTimestamp":1779583447,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology Limited ( HKG:1061 ) is about to trade ex-dividend in the next three days. The ex-dividend date is...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1061/essex-bio-technology-shares/news/essex-bio-technology-limited-hkg1061-looks-interesting-and-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1061/essex-bio-technology-shares/news/essex-bio-technology-limited-hkg1061-looks-interesting-and-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VIG","BK4585","BK1161","01061","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150350482","title":"Essex Bio-Tech: April 2026 Monthly Return Shows Stable Share Capital and Full Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1150350482","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150350482?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:02","pubTimestamp":1777885365,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology Limited filed its Monthly Return for the period ended 30 April 2026, confirming that both authorised and issued share capital remained unchanged during the month. The company’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127053235","title":"ESSEX BIO-TECH 2025年度营收增长8.6%，三大业务板块表现稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=1127053235","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127053235?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:53","pubTimestamp":1774947228,"startTime":"0","endTime":"0","summary":"ESSEX BIO-TECH于2025财政年度（截至2025年12月31日）录得综合营业额约港币1,813.8百万，同比上升8.6%，同期净利润约港币318.1百万，同比增长3.5%。公司主要收入来自中国内地市场，折算人民币计，全年收入约为人民币16.72亿元，净利润约人民币2.93亿元。旗舰生物制剂Beifushu®和Beifuji®系列合计占总营业额约83.5%，继续成为主要业绩增长的动力。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195907302","title":"ESSEX BIO-TECH unveils AGM agenda: HK$0.07 final dividend, 20% share issue mandate, 10% buy-back authority","url":"https://stock-news.laohu8.com/highlight/detail?id=1195907302","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195907302?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:47","pubTimestamp":1774946831,"startTime":"0","endTime":"0","summary":"ESSEX BIO-TECH has released its 2026 AGM circular outlining key resolutions to be tabled on 26 May 2026 in Hong Kong. Dividend   • Board proposes a cash final dividend of HK$0.07 per share for FY...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623304841","title":"Essex Bio-Tech announces annual general meeting, issues proxy form","url":"https://stock-news.laohu8.com/highlight/detail?id=2623304841","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623304841?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:37","pubTimestamp":1774946224,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology schedules annual general meeting in Hong Kong on May 26, 2026.Shareholders will review audited consolidated financial statements and related directors’ and auditors’ reports for fiscal 2025.Votes set on re-election of directors, including Fang Haizhou, Fung Chi Ying, Yan Man Sing Frankie.Meeting will consider re-appointment of BDO as auditor.Resolutions include final dividend of HKD 0.07 per share, share issuance mandate, share repurchase mandate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Essex Bio-Technology Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLLjcBv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623304847","title":"Essex Bio-Tech publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2623304847","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623304847?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:36","pubTimestamp":1774946160,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology annual report for year ended Dec. 31, 2025 outlined continued growth despite ongoing centralized procurement pressure on flagship bFGF biologics.Product mix remained concentrated in Beifushu and Beifuji, supported by indication expansion and broader patient access across China.International push advanced with Beifushu introduced in Singapore via Special Access Route at Singapore National Eye Centre.Pipeline update highlighted completion of global Phase 3 program for EB12-20145P in wet age-related macular degeneration, with China BLA accepted in Aug. 2025.Portfolio expansion accelerated through partnerships spanning AI-based retinal services, consumer health commercialization in China, and dental-maxillofacial distribution rights across Greater China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbpFw63:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623048903","title":"Essex Bio-Tech releases 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2623048903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623048903?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:35","pubTimestamp":1774946144,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology ESG report for year ended Dec. 31, 2025 set Scope 1-3 greenhouse gas emissions at 4,446.62 metric tons, with emissions intensity at 0.017 kg per unit of production volume.Electricity consumption totaled 6,799,221 kWh, with intensity at 0.026 kWh per unit of production volume.Water consumption reached 61,813 cubic meters, with intensity at 0.00024 cubic meters per unit of production volume.Hazardous waste totaled 2.4 metric tons, with non-hazardous waste at 29.75 metric tons.Report highlighted patient reach of more than 15 million for Beifushu ophthalmic products, with more than 7.66 million served by Beifuji and Beifuxin surgical products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Essex Bio-Technology Limited ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL3Zk3js:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157400728","title":"ESSEX BIO-TECH (01061) Deemed Undervalued by Guoyuan International, Analyst Recommends Close Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=1157400728","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157400728?lang=en_us&edition=fundamental","pubTime":"2026-03-26 11:26","pubTimestamp":1774495587,"startTime":"0","endTime":"0","summary":"Guoyuan International has released a research report stating that ESSEX BIO-TECH (01061) achieved a turnover of HKD 1.814 billion in 2025, an increase of 8.6% compared to 2024, primarily driven by...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621313037","title":"Essex Bio-Technology's Profit, Revenue Rise in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2621313037","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621313037?lang=en_us&edition=fundamental","pubTime":"2026-03-24 11:34","pubTimestamp":1774323252,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology's  profit attributable to owners rose to HK$318.1 million for 2025, up from HK$307.2 million a year earlier, according to a Monday Hong Kong bourse filing.Shares of the firm were up more than 1% in Tuesday morning trade.Earnings per share came in at HK$0.5610, compared with HK$0.5318 a year earlier.Revenue rose to HK$1.81 billion from HK$1.67 billion.The board recommended a final dividend of HK$0.07 per share for 2025, payable on June 12 to shareholders whose names appear on the register of members as on June 3.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170662886","title":"ESSEX BIO-TECH Reports Annual Profit of HK$318 Million, Up 3.54% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1170662886","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170662886?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:22","pubTimestamp":1774264938,"startTime":"0","endTime":"0","summary":"ESSEX BIO-TECH (01061) announced its full-year results for the period ended December 31, 2025. The company achieved revenue of HK$1.814 billion, representing an increase of 8.62% compared to the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162158720","title":"Essex Bio-Tech Declares HKD 0.07 Final Dividend for FY 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1162158720","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162158720?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:20","pubTimestamp":1774264846,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology Limited announced on 23 March 2026 that its board has proposed a final ordinary dividend of HKD 0.07 per share for the financial year ended 31 December 2025. The dividend is...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161428591","title":"ESSEX BIO-TECH (01061) to Distribute Final Dividend of HK$0.07 per Share on June 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1161428591","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161428591?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:14","pubTimestamp":1774264460,"startTime":"0","endTime":"0","summary":"ESSEX BIO-TECH (01061) announced that it will distribute a final dividend of HK$0.07 per share for the fiscal year ended December 31, 2025, on June 12, 2026.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","VIG","01061","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621770864","title":"Essex Bio-Technology reports 2025 revenue of HKD 1.8 billion on 8.6% growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770864","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770864?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:10","pubTimestamp":1774264258,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology reported regulatory approvals in China for multi-dose versions of diquafosol sodium eye drops and sodium hyaluronate eye drops, expanding its commercial ophthalmology portfolio.The company said the additions broaden its product mix in eye care, supporting competitive positioning in a market where it already operates a nationwide sales network.Management also highlighted ongoing late-stage investment programs in ophthalmology that are intended to extend the pipeline beyond its core bFGF franchise, which contributed about 83.5% of revenue.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Essex Bio-Technology Limited published the original content used to generate this news brief via IIS, the Issuer Information Service ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL4TQqB7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621770861","title":"BRIEF-Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770861","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770861?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:10","pubTimestamp":1774264248,"startTime":"0","endTime":"0","summary":"BRIEF-Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per ShareMarch 23  - Essex Bio-Technology Ltd 1061.HK:FINAL DIVIDEND OF HK$0.07 PER ORDINARY SHAREFY PROFIT ATTRIBUTABLE HKD318.1 MILLIONFY REVENUE HKD 1,813.8 MILLIONFurther company coverage: 1061.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B06N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621777038","title":"Essex Bio-Technology Ltd -  Final Dividend of HK$0.07 per Ordinary Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777038?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:06","pubTimestamp":1774263961,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B06N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621777745","title":"Essex Bio-Technology FY Revenue HKD 1,813.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621777745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621777745?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:05","pubTimestamp":1774263949,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nPLX7F9587:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122858945","title":"Essex Bio-Technology (01061) Publishes February 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1122858945","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122858945?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:06","pubTimestamp":1772528762,"startTime":"0","endTime":"0","summary":"Essex Bio-Technology Limited (01061) reported that its authorized share capital remained at 1.00 billion ordinary shares, each with a par value of HKD 0.10, totaling HKD 100.00 million as of February...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126880189","title":"HK Stock Movement | ESSEX BIO-TECH (01061) Rises Nearly 9% in Afternoon Session; Company to Showcase Multiple Core Ophthalmology Products at APAO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1126880189","media":"Stock News","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126880189?lang=en_us&edition=fundamental","pubTime":"2026-01-27 14:44","pubTimestamp":1769496262,"startTime":"0","endTime":"0","summary":"ESSEX BIO-TECH (01061) rose nearly 9% in the afternoon session. As of the time of writing, the stock was up 5.83%, trading at HK$4.36, with a turnover of HK$5.2576 million. The company recently...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603260694","title":"BRIEF-Essex Bio-Technology's Unit Enters Exclusive Distribution Agreement With Osteopore International","url":"https://stock-news.laohu8.com/highlight/detail?id=2603260694","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603260694?lang=en_us&edition=fundamental","pubTime":"2026-01-15 18:34","pubTimestamp":1768473269,"startTime":"0","endTime":"0","summary":"BRIEF-Essex Bio-Technology's Unit Enters Exclusive Distribution Agreement With Osteopore InternationalJan 15 (Reuters) - Essex Bio-Technology Ltd 1061.HK:UNIT ENTERS EXCLUSIVE DISTRIBUTION AGREEMENT W","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.essexbio.com","stockEarnings":[{"period":"1week","weight":-0.0751},{"period":"1month","weight":-0.1247},{"period":"3month","weight":-0.3115},{"period":"6month","weight":-0.3046},{"period":"1year","weight":-0.4307},{"period":"ytd","weight":-0.264}],"compareEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":-0.0249},{"period":"3month","weight":-0.0196},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0676},{"period":"ytd","weight":-0.0147}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Essex Bio-Technology Ltd is an investment holding company mainly engaged in the production and sale of biopharmaceuticals for the treatment of body surface trauma and eye injuries. The Company operates its business through three segments. The Surgical segment is engaged in the development, manufacture and sale of Beifuji series products such as Beifuji spray, Beifuji lyophilized powder, Beifuxin gel and others. The Ophthalmology segment is engaged in the development, manufacture and sale of Beifuji series products such as Beifushu eye drops, Beifushu eye gel, Beifushu single-dose eye drops and others. The Provision of Services segment is engaged in the provision of healthtech e-platform related medical services.","yearOnYearQuotes":[{"month":1,"riseRate":0.733333,"avgChangeRate":0.036282},{"month":2,"riseRate":0.6,"avgChangeRate":0.051619},{"month":3,"riseRate":0.533333,"avgChangeRate":0.042805},{"month":4,"riseRate":0.466667,"avgChangeRate":0.031977},{"month":5,"riseRate":0.4,"avgChangeRate":-0.012005},{"month":6,"riseRate":0.4,"avgChangeRate":0.023375},{"month":7,"riseRate":0.357143,"avgChangeRate":-0.026551},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.002168},{"month":9,"riseRate":0.533333,"avgChangeRate":0.03471},{"month":10,"riseRate":0.333333,"avgChangeRate":0.013996},{"month":11,"riseRate":0.466667,"avgChangeRate":0.008914},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.018984}],"exchange":"SEHK","name":"ESSEX BIO-TECH","nameEN":"ESSEX BIO-TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ESSEX BIO-TECH(01061),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ESSEX BIO-TECH(01061) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ESSEX BIO-TECH,01061,ESSEX BIO-TECH股票,ESSEX BIO-TECH股票老虎,ESSEX BIO-TECH股票老虎国际,ESSEX BIO-TECH行情,ESSEX BIO-TECH股票行情,ESSEX BIO-TECH股价,ESSEX BIO-TECH股市,ESSEX BIO-TECH股票价格,ESSEX BIO-TECH股票交易,ESSEX BIO-TECH股票购买,ESSEX BIO-TECH股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ESSEX BIO-TECH(01061),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ESSEX BIO-TECH(01061) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}